Robotic assisted radical prostatectomy improves biochemical recurrence-free survival: The PROCA-life study

机器人辅助根治性前列腺切除术可提高生化复发无进展生存期:PROCA-life 研究

阅读:4

Abstract

Robotic-assisted laparoscopic prostatectomy (RALP) is the preferred surgical technique compared to radical retropubic prostatectomy (RRP), but reports have been inconsistent on the effect of RALP on positive surgical margins (PSM) and biochemical recurrence (BCR). This study includes 420 men who participated in the population-based Tromsø study and PROCA-life study, diagnosed with prostate cancer (PCa) during 1995–2022, and treated with curative surgery. Overall, 171 PCa patients underwent open surgery with RRP, performed 1995–2012, and 249 PCa patients underwent RALP, performed 2012–2022. Preoperative and postoperative clinical characteristics were recorded. Multivariable Cox regression models presented with hazard ratios (HR) were used to study the association between surgical technique, preoperative and postoperative characteristics, and BCR. Overall, 72 patients (42.1%) in the RRP group, and 47 patients (18.9%) in the RALP group had BCR. Median time from surgery to BCR was 26.9 (IQR 10.2–58.0) months and 24.5 (IQR 15.4–46.9) months, respectively. PSM were three times more frequent in the RRP group compared to the RALP group (42.9% vs. 14.0%). Five-year BCR-free survival in the RRP group was 67% (95% CI 59–74), in the RALP group 81% (95% CI 75–86). The RALP procedure independently decreased the risk of BCR compared to RRP (HR 0.52; 95% CI 0.34–0.80, p = 0.003). PCa patients who had PSM had a doubled risk of BCR compared with patients with negative surgical margins (HR 2.00; 95% CI 1.31–3.05, p < 0.001). Patients with ISUP grade 3–5 (vs. grade 1) had an increased risk of BCR, highest with ISUP 4/5 (HR 3.44, 95% CI 1.79–6.61, p < 0.001). Implementation of RALP reduced the risk of biochemical recurrence compared to RRP, partly explained by the markedly lower PSM rate after RALP.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。